Actively Recruiting
MIVetsCan: Cannabidiol (CBD)-Care Trial
Led by Kevin Boehnke · Updated on 2025-05-21
468
Participants Needed
1
Research Sites
146 weeks
Total Duration
On this page
Sponsors
K
Kevin Boehnke
Lead Sponsor
M
Michigan, State of, Licensing and Regulatory Affairs
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research is studying the effects of cannabidiol (CBD), an active component from cannabis (a.k.a. marijuana), on Veterans' chronic pain. The purpose of this study is to better understand if CBD can improve pain symptoms in Veterans with chronic pain. Eligible participants will be randomly assigned to receive either placebo medication (not active) or CBD during the study period. The study hypotheses: \- CBD would improve overall pain symptoms compared to placebo
CONDITIONS
Official Title
MIVetsCan: Cannabidiol (CBD)-Care Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ability to read and speak English well enough for consent and reporting
- Armed Services Veteran
- Enrolled in MIVetsCan Pain Registry for at least 4 weeks and agree to continue
- Reports moderate to severe chronic pain as defined by protocol
- Currently using or interested in cannabis for pain management
- Willing to refrain from or not increase THC or other cannabis use during study
- Agree to use acceptable birth control if of reproductive potential
- Agree not to donate sperm or eggs during study drug use
- Willing to attend all study visits (including virtual)
- Able to take and swallow study medication and follow treatment
- Willing to wear Fitbit or similar sensor for data collection
- Willing to complete daily symptom and drug use diary via smartphone
You will not qualify if you...
- Not an Armed Services Veteran
- Unable to provide informed consent or communicate in English
- Pregnant or nursing
- Planning to move out of a state with legal recreational marijuana use during study
- Risk of imminent harm such as suicidal ideation
- Any condition or situation preventing satisfactory study completion
- Participation in other clinical trials during study period
- Medical or psychiatric conditions precluding participation (e.g., psychosis)
- Serious or unstable liver disease
- Major neurological disorders (e.g., dementia, Parkinson's disease, epilepsy)
- New cancer diagnosis within past 3 years (except certain localized skin cancers)
- Current use of valproate or clobazam
- Allergies to sesame oil or cannabis/cannabinoids
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Michigan
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
Research Team
V
Vivian Kurtz, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here